Goldman Sachs’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$111K Sell
2022
Q2
$225K Buy
2022
Q1
$1.23M Buy
2021
Q4
$2.22M Buy
2021
Q3
$2.53M Buy
2021
Q2
$1.9M Sell
2021
Q1
$3.77M Buy
2020
Q4
$807K Buy
2020
Q3
$350K Sell
2020
Q2
$703K Buy
2020
Q1
$220K Sell
2019
Q4
$303K Buy
2019
Q3
$146K Sell
2019
Q2
$253K Buy
2019
Q1
$163K Sell
2018
Q4
$100K Buy